Prion protein interconversions and the transmissible spongiform encephalopathies

Structure

Volumn 7, Issue 10, 1999, Pages

  Horiuchi, Motohiro ^a,b   Caughey, Byron ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

BRAIN SPONGIOSIS; CONFORMATIONAL TRANSITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE; SHORT SURVEY;

EID: 0033570204     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(00)80049-0     Document Type: Review

References (96)

1. 1. Weissmann, C. (1999). Molecular genetics of transmissible spongiform encephalopathies. J. Biol. Chem. 274, 3-6.
2. 2. Caughey, B. & Chesebro, B. (1997). Prion protein and the transmissible spongiform encephalopathies. Trends Cell Biol. 7, 56-62.
3. 3. Prusiner, S.B. (1998). Prions. Proc. Natl Acad. Sci. USA 95, 13363-13383.
4. 4. Pan, K.-M., et al., & Prusiner, S.B. (1993). Conversion of α-helices into β-sheets features in the formation of the scrapie prion protein. Proc. Natl Acad. Sci. USA 90, 10962-10966.
5. 5. Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R. & Wüthrich, K. (1996). NMR structure of the mouse prion protein domain PrP(121-231). Nature 382, 180-182.
6. 6. Riek, R., Hornemann, S., Wider, G., Glockshuber, R. & Wüthrich, K. (1997). NMR characterization of the full-length recombinant murine prion protein, mPrP(23-21). FEBS Lett. 413, 282-288.
7. 7. Hornemann, S., et al., & Glockshuber, R. (1997). Recombinant full-length murine prion protein, mPrP(23-231): purification and spectroscopic characterization. FEBS Lett. 413, 277-281.
8. 8. Donne, D.G., et al., & Dyson, H.J. (1997). Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc. Natl Acad. Sci. USA 94, 13452-13457.
9. 9. Liu, H., et al., & James, T.L. (1999). Solution structure of Syrian hamster prion protein rPrP(90-231). Biochemistry 38, 5362-5377.
10. 10. Caughey, B.W., Dong, A., Bhat, K.S., Ernst, D., Hayes, S.F. & Caughey, W.S. (1991). Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30, 7672-7680.
11. 11. Safar, J., Ceroni, M., Gajdusek, D.C. & Gibbs, C.J., Jr. (1991). Differences in the membrane interaction of scrapie amyloid precursor proteins in normal and scrapie-or Creutzfeldt-Jakob disease-infected brains. J. Infect. Dis. 163, 488-494.
12. 12. Nguyen, J.T., et al., & Kirschner, D.A. (1995). X-ray diffraction of scrapie prion rods and PrP peptides. J. Mol. Biol. 252, 412-422.
13. 13. Caughey, B., Raymond, G.J. & Bessen, R.A. (1998). Strain-dependent differences in β-sheet conformations of abnormal prion protein. J. Biol. Chem. 273, 32230-32235.
14. 14. Bessen, R.A. & Marsh, R.F. (1994). Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68, 7859-7868.
15. 15. Bessen, R.A., Kocisko, D.A., Raymond, G.J., Nandan, S., Lansbury, P.T., Jr. & Caughey, B. (1995). Nongenetic propagation of strain-specific phenotypes of scrapie prion protein. Nature 375, 698-700.
16. 16. Tagliavini, F., et al., & Frangione, B. (1994). Amyloid fibrils in Gerstmann-Straussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 79, 695-703.
17. 17. Muramoto, T., Scott, M., Cohen, F.E. & Prusiner, S.B. (1996). Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc. Natl Acad. Sci. USA 93, 15457-15462.
18. 18. Kascsak, R.J., et al., & Diringer, H. (1986). Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J. Virol. 59, 676-683.
19. 19. Monari, L., et al., & Autilio-Gambetti, L. (1994). Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc. Natl Acad. Sci. USA 91, 2939-2842.
20. 20. Collinge, J., Sidle, K.C.L., Meads, J., Ironside, J. & Hill, A.F. (1996). Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383, 685-690.
21. 21. Somerville, R.A., Chong, A., Mulqueen, O.U., Birkett, C.R., Wood, S.C. & Hope, J. (1997). Biochemical typing of scrapie strains. Nature 386, 564.
22. 22. Hope, J., et al., & Bostock, C.J. (1999). Molecular analysis of ovine prion protein identifies similarities between BSE and an experimental isolate of natural scrapie, CH1641. J. Gen. Virol. 80, 1-4.
23. 23. Safar, J., et al., & Prusiner, S.B. (1998). Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4, 1157-1165.
24. 24. Rubenstein, R., Gray, P.C., Wehlburg, C.M., Wagner, J.S. & Tisone, G.C. (1998). Detection and discrimination of PrPSc by multi-spectral ultraviolet fluorescence. Biochem. Biophys. Res. Commun. 246, 100-106.
25. 25. McKinley, M.P., et al., & Prusiner, S.B. (1991). Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J. Virol. 65, 1340-1351.
26. 26. Giaccone, G., et al., & Tagliavini, F. (1992). Prion protein preamyloid and amyloid deposits in Gerstmann-Straussler-Scheinker disease, Indiana kindred. Proc. Natl Acad. Sci. USA 89, 9349-9353.
27. 27. Jeffrey, M., Goodsir, C.M., Bruce, M.E., McBride, P.A. & Farquhar, C. (1994). Morphogenesis of amyloid plaques in 87V murine scrapie. Neuropath. Appl. Neuropath. 20, 535-542.
28. 28. Caughey, B., Kocisko, D.A., Raymond, G.J. & Lansbury, P.T. (1995). Aggregates of scrapie associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem. Biol. 2, 807-817.
29. 29. Caughey, B., Raymond, G.J., Kocisko, D.A. & Lansbury, P.T., Jr. (1997). Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. J. Virol. 71, 4107-4110.
30. 30. Weissmann, C. (1991). A unified theory of prion propagation. Nature 352, 679-683.
31. 31. Griffith, J.S. (1967). Self-replication and scrapie. Nature 215, 1043-1044.
32. 32. Bolton, D.C. & Bendheim, P.E. (1988). A modified host protein model of scrapie. In Novel Infectious Agents and the Central Nervous System. (Bock, G. & Marsh, J., eds), pp. 164-181, John Wiley & Sons, Chichester, UK.
33. 33. Gadjusek, D.C. (1988). Transmissible and nontransmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to β-pleated configurations. J. Neuroimmunol. 20, 95-110.
34. 34. Jarrett, J.T. & Lansbury, P.T., Jr. (1993). Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
35. 35. Lansbury, P.T., Jr. & Caughey, B. (1995). The chemistry of scrapie infection: implications of the 'ice 9' metaphor. Chem. Biol. 2, 1-5.
36. 36. Swietnicki, W., Petersen, R., Gambetti, P. & Surewicz, W.K. (1997). pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231). J. Biol. Chem. 272, 27517-27520.
37. 37. Zhang, H., et al., & Cohen, F.E. (1997). Physical studies of conformational plasticity in a recombinant prion protein. Biochemistry 36, 3543-3553.
38. 38. Hornemann, S. & Glockshuber, R. (1998). A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. Proc. Natl Acad. Sci. USA 95, 6010-6014.
39. 39. Jackson, G.S., et al., & Collinge, J. (1999). Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283, 1935-1937.
40. 40. Prusiner, S.B., Groth, D., Serban, A., Stahl, N. & Gabizon, R. (1993). Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc. Natl Acad. Sci. USA 90, 2793-2797.
41. 41. Hope, J. (1994). The nature of the scrapie agent: the evolution of the virino. Ann. NY Acad. Sci. 724, 282-289.
42. 42. Eigen, M. (1996). Prionics or the kinetic basis of prion diseases. Biophys. Chem. 63, A1-18.
43. 43. Masel, J., Jansen, V.A. & Nowak, M.A. (1999). Quantifying the kinetic parameters of prion replication. Biophys. Chem. 77, 139-152.
44. 44. Priola, S.A. (1999). Prion protein and species barriers in the transmissible spongiform encephalopathies. Biomed. Pharmacother. 53, 27-33.
45. 45. Kocisko, D.A., et al., & Caughey, B. (1994). Cell-free formation of protease-resistant prion protein. Nature 370, 471-474.
46. 46. Kocisko, D.A., Priola, S.A., Raymond, G.J., Chesebro, B., Lansbury, P.T., Jr. & Caughey, B. (1995). Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc. Natl Acad. Sci. USA 92, 3923-3927.
47. 47. Bossers, A., Belt, P.B.G.M., Raymond, G.J., Caughey, B., de Vries, R. & Smits, M.A. (1997). Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. Proc. Natl Acad. Sci. USA 94, 4931-4936.
48. 48. Raymond, G.J., et al., & Caughey, B. (1997). Molecular assessment of the transmissibilities of BSE and scrapie to humans. Nature 388, 285-288.
49. 49. Hill, A.F., Antoniou, M. & Collinge, J. (1999). Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 80, 11-14.
50. 50. Chabry, J., Caughey, B. & Chesebro, B. (1998). Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J. Biol. Chem. 273, 13203-13207.
51. 51. Caughey, W.S., Raymond, L.D., Horiuchi, M. & Caughey, B. (1998). Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc. Natl Acad. Sci. USA 95, 12117-12122.
52. 52. Demaimay, R., Harper, J., Gordon, H., Weaver, D., Chesebro, B. & Caughey, B. (1998). Structural aspects of Congo red as an inhibitor of protease-resistant prion protein formation. J. Neurochem. 71, 2534-2541.
53. 53. Bessen, R.A., Raymond, G.J. & Caughey, B. (1997). In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices. J. Biol. Chem. 272, 15227-15231.
54. 54. DebBurman, S.K., Raymond, G.J., Caughey, B. & Lindquist, S. (1997). Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc. Natl Acad. Sci. USA 94, 13938-13943.
55. 55. Horiuchi, M. & Caughey, B. (1999). Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J. 18, 3193-3203.
56. 56. Saborio, G.P., et al., & Frangione, B. (1999). Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. Biochem. Biophys. Res. Commun. 258, 470-475.
57. 57. Chabry, J., Priola, S.A., Wehrly, K., Nishio, J., Hope, J. & Chesebro, B. (1999). Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence. J. Virol. 73, 6245-6250.
58. 58. Herrmann, L.M. & Caughey, B. (1998). The importance of the disulfide bond in prion protein conversion. Neuroreport 9, 2457-2461.
59. 59. Kaneko, K., et al., & Prusiner, S.B. (1997). Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl Acad. Sci. USA 94, 10069-10074.
60. 60. Priola, S.A., Caughey, B., Race, R.E. & Chesebro, B. (1994). Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J. Virol. 68, 4873-4878.
61. 61. Scott, M.R., Kohler, R., Foster, D. & Prusiner, S.B. (1992). Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci. 1, 986-997.
62. 62. Priola, S.A. & Chesebro, B. (1995). A single hamster amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J. Virol. 69, 7754-7758.
63. 63. Safar, J., Roller, P.P., Gajdusek, D.C. & Gibbs, C.J., Jr. (1993). Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J. Biol. Chem. 268, 20276-20284.
64. 64. Safar, J., Roller, P.P., Gajdusek, D.C. & Gibbs, C.J., Jr. (1994). Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate. Biochemistry 33, 8375-8383.
65. 65. Kocisko, D.A., Lansbury, P.T., Jr. & Caughey, B. (1996). Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. Biochemistry 35, 13434-13442.
66. 66. Oesch, B., Jensen, M., Nilsson, P. & Fogh, J. (1994). Properties of the scrapie prion protein: quantitative analysis of protease resistance. Biochemistry 33, 5926-5931.
67. 67. McKenzie, D., Bartz, J., Mirwald, J., Olander, D., Marsh, R. & Aiken, J. (1998). Reversibility of scrapie inactivation is enhanced by copper. J. Biol. Chem. 273, 25545-25547.
68. 68. Riesner, D., et al., & Prusiner, S.B. (1996). Disruption of prion rods generates 10-nm spherical particles having high α-helical content and lacking scrapie infectivity. J. Virol. 70, 1714-1722.
69. 69. Wille, H. & Prusiner, S.B. (1999). Ultrastructural studies on scrapie prion protein crystals obtained from reverse micellar solutions. Biophys. J. 76, 1048-1062.
70. 70. Post, K., et al., & Riesner, D. (1998). Rapid acquisition of β-sheet structure in the prion protein prior to multimer formation. Biol. Chem. 379, 1307-1317.
71. 71. Shaked, G.M., Fridlander, G., Meiner, Z., Taraboulos, A. & Gabizon, R. (1999). Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity. J. Biol. Chem. 274, 17981-17986.
72. 72. Gasset, M., et al., & Prusiner, S.B. (1992). Predicted α-helical regions of the prion protein when synthesized as peptides form amyloid. Proc. Natl Acad. Sci. USA 89, 10940-10944.
73. 73. Goldfarb, L.G., Brown, P., Haltia, M., Ghiso, J., Frangione, B. & Gajdusek, D.C. (1993). Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeld-Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils. Proc. Natl Acad. Sci. USA 90, 4451-4454.
74. 74. Come, J.H., Fraser, P.E. & Lansbury, P.T., Jr. (1993). A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl Acad. Sci. USA 90, 5959-5963.
75. 75. Come, J.H. & Lansbury, P.T., Jr. (1994). Predisposition of prion protein homozygotes to Creutzfeldt-Jakob disease can be explained by a nucleation-dependent polymerization mechanism. J. Am. Chem. Soc. 116, 4109-4110.
76. 76. Selvaggini, C., et al., & Salmona, M. (1993). Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Res. Commun. 194, 1380-1386.
77. 77. Kaneko, K., et al., & Prusiner, S.B. (1995). Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform. Proc. Natl Acad. Sci. 92, 11160-11164.
78. 78. Hornemann, S. & Glockshuber, R. (1996). Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein. J. Mol. Biol. 261, 614-619.
79. 79. Wildegger, G., Liemann, S. & Glockshuber, R. (1999). Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates. Nat. Struct. Biol. 6, 550-553.
80. 80. Caughey, B. & Raymond, G.J. (1991). The scrapie-associated form of PrP is made from a cell surface precursor that is both protease-and phospholipase-sensitive. J. Biol. Chem. 266, 18217-18223.
81. 81. Caughey, B., Raymond, G.J., Ernst, D. & Race, R.E. (1991). N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J. Virol. 65, 6597-6603.
82. 82. Borchelt, D.R., Taraboulos, A. & Prusiner, S.B. (1992). Evidence for synthesis of scrapie prion protein in the endocytic pathway. J. Biol. Chem. 267, 16188-16199.
83. 83. Turk, E., Teplow, D.B., Hood, L.E. & Prusiner, S.B. (1988). Purification and properties of the cellular and scrapie hamster prion proteins. Eur. J. Biochem. 176, 21-30.
84. 84. Kitamoto, T., Iizuka, R. & Tateishi, J. (1993). An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem. Biophys. Res. Commun. 192, 525-531.
85. 85. Chen, S.G., et al., & Gambetti, P. (1997). Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat. Med. 3, 1009-1015.
86. 86. Lehmann, S. & Harris, D.A. (1996). Mutant and infectious prion proteins display common biochemical properties in cultured cells. J. Biol. Chem. 271, 1633-1637.
87. 87. Lehmann, S. & Harris, D.A. (1995). A mutant prion protein displays an aberrant membrane association when expressed in cultured cells. J. Biol. Chem. 270, 24589-24597.
88. 88. Petersen, R.B., Parchi, P., Richardson, S.L., Urig, C.B. & Gambetti, P. (1996). Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J. Biol. Chem. 271, 12661-12668.
89. 89. Singh, N., et al., & Petersen, R.B. (1997). Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation. J. Biol. Chem. 272, 28461-28470.
90. 90. Priola, S.A. & Chesebro, B. (1998). Abnormal properties of prion protein with insertional mutations in different cell types. J. Biol. Chem. 273, 11980-11985.
91. 91. Hegde, R.S., et al., & Lingappa, V.R. (1998). A transmembrane form of the prion protein in neurodegenerative disease. Science 279, 827-834.
92. 92. Muramoto, T., DeArmond, S.J., Scott, M., Telling, G.C., Cohen, F.E. & Prusiner, S.B. (1997). Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an α-helix. Nat. Med. 3, 750-755.
93. 93. Swietnicki, W., Petersen, R.B., Gambetti, P. & Surewicz, W.K. (1998). Familial mutations and the thermodynamic stability of the recombinant human prion protein. J. Biol. Chem. 273, 31048-31052.
94. 94. Liemann, S. & Glockshuber, R. (1999). Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38, 3258-3267.
95. 95. Cappai, R., et al., & Barrow, C.J. (1999). Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation. Biochemistry 38, 3280-3284.
96. 96. Riek, R., Wider, G., Billeter, M., Hornemann, S., Glockshuber, R. & Wüthrich, K. (1998). Prion protein NMR structure and familial human spongiform encephalopathies. Proc. Natl Acad. Sci. USA 95, 11667-11672.